You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb158100 |
---|---|
Category | Antibodies |
Description | PARK9 antibody |
Species/Host | Rabbit |
Clonality | Polyclonal |
Tested applications | ELISA, ICC, IF, IHC-Fr, IHC-P |
Predicted Reactivity | Bovine, Equine, Human, Mouse, Porcine, Rabbit |
Reactivity | Rat |
Isotype | IgG |
Immunogen | KLH conjugated synthetic peptide derived from human ATP13A2 (1001-1080/1180 aa) |
Concentration | 1mg/ml |
Dilution range | IHC-P=1:100-500, IHC-F=1:100-500, ICC=1:100-500, IF=1:100-500, ELISA=1:5000-10000 |
Form/Appearance | Liquid |
Conjugation | Unconjugated |
MW | 129 kDa |
Target | ATP13A2 |
UniProt ID | Q9NQ11 |
Storage | Shipped at 4°C. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. |
Buffer/Preservatives | 0.01M TBS(pH7.4) with 1% rAlbumin, 0.03% Proclin300 and 50% Glycerol. |
Alternative names | PARK9; AT132_HUMAN; Atp13a2; ATPase type 13A2; CLN Read more... |
Note | For research use only |
Expiration Date | 12 months from date of receipt. |
Chen, Qian et al. Knockdown of Parkinson's disease-related gene ATP13A2 reduces tumorigenesis via blocking autophagic flux in colon cancer Cell Biosci, 10, 144 (2020)
Immunohistochemical staining of rat brain tissue using PARK9 antibody.
Filter by Rating